TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 79.35
-3.95 (-4.74%)
Jan 21, 2026, 1:25 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 33.06 billion as of January 20, 2026.
Market Cap
33.06B
Enterprise Value
32.37B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
79.35
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 33.06B, an increase of 254.47%. That is a compound annual growth rate of 802.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 36.95B | -18.97% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |